Abiopharma

New Form 8-K - Marker Therapeutics, Inc. Filed: 2025-06-17 AccNo: 0001104659-25-060092 Size: 217 KB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits